BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38538635)

  • 1. Modified streptavidin-biotin based lateral flow test strip for rapid detection of SARS-CoV-2 S1 antigen in saliva samples.
    Kamel M; Atta S; Maher S; Abd Elaziz H; Demerdash Z
    Sci Rep; 2024 Mar; 14(1):7319. PubMed ID: 38538635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold conjugated nanobodies in a signal-enhanced lateral flow test strip for rapid detection of SARS-CoV-2 S1 antigen in saliva samples.
    Maher S; Kamel M; Demerdash Z; El Baz H; Sayyouh O; Saad A; Ali N; Salah F; Atta S
    Sci Rep; 2023 Jun; 13(1):10643. PubMed ID: 37391465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an immunochromatography-based rapid antigen test, Inspecter Kowa® SARS-CoV-2, using saliva specimens for the detection of SARS-CoV-2.
    Kodana M; Orihara Y; Tezuka M; Takahashi R; Noguchi S; Matsuzaki N; Takada T; Kobari N; Ogane K; Kawamura R; Kawamura T; Takeuchi S; Kamiyama Y; Shiomi R; Aoyagi R; Saito M; Kusano T; Nakaya N; Kaneko S; Morita H; Uchida Y; Yazawa H; Sekiya R; Katayama K; Mikami S; Sato T; Tarumoto N; Kobayashi T; Nakamoto H; Maeda T
    J Infect Chemother; 2023 Jun; 29(6):586-591. PubMed ID: 36849098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs : A Systematic Review and Meta-analysis.
    Bastos ML; Perlman-Arrow S; Menzies D; Campbell JR
    Ann Intern Med; 2021 Apr; 174(4):501-510. PubMed ID: 33428446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Performance of Direct RT-PCR Testing of Raw Saliva for Detection of SARS-CoV-2 in Symptomatic and Asymptomatic Individuals.
    Castillo-Bravo R; Lucca N; Lai L; Marlborough K; Brychkova G; Sakhteh MS; Lonergan C; O'Grady J; Alikhan NF; Trotter AJ; Page AJ; Smyth B; McKeown PC; Feenstra JDM; Ulekleiv C; Sorel O; Gandhi M; Spillane C
    Microbiol Spectr; 2022 Dec; 10(6):e0222922. PubMed ID: 36409097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
    Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
    Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2.
    Callahan C; Ditelberg S; Dutta S; Littlehale N; Cheng A; Kupczewski K; McVay D; Riedel S; Kirby JE; Arnaout R
    Microbiol Spectr; 2021 Sep; 9(1):e0016221. PubMed ID: 34406838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
    Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
    Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Invasive Detection of SARS-CoV-2 Antigen in Saliva versus Nasopharyngeal Swabs Using Nanobodies Conjugated Gold Nanoparticles.
    Kamel M; Maher S; El-Baz H; Salah F; Sayyouh O; Demerdash Z
    Trop Med Infect Dis; 2022 Jun; 7(6):. PubMed ID: 35736981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients.
    Yu F; Xie G; Zheng S; Han D; Bao J; Zhang D; Feng B; Wang Q; Zou Q; Wang R; Yang X; Chen W; Lou B; Chen Y
    Front Cell Infect Microbiol; 2021; 11():685640. PubMed ID: 34164346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of three saliva qualitative antigen testing kits for the detection of SARS-CoV-2 among mainly symptomatic patients in Japan.
    Terada N; Akashi Y; Takeuchi Y; Ueda A; Notake S; Nakamura K; Suzuki H
    J Infect Chemother; 2023 Jul; 29(7):654-659. PubMed ID: 36894015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of saliva and nasopharyngeal swab for SARS-CoV-2 detection using RT-qPCR among COVID-19 suspected patients at Jigjiga, Eastern Ethiopia.
    Tahir B; Weldegebreal F; Ayele F; Ayana DA
    PLoS One; 2023; 18(3):e0282976. PubMed ID: 36913377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Feasibility of a Saliva-Based Antigen Qualitative Test for Severe Acute Respiratory Syndrome Coronavirus 2.
    Saito N; Kosaihira S
    J Nippon Med Sch; 2022 Nov; 89(5):500-505. PubMed ID: 35644552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test.
    Sun Q; Li J; Ren H; Pastor L; Loginova Y; Madej R; Taylor K; Wong JK; Zhang Z; Zhang A; Lu CM; Sha MY
    PLoS One; 2021; 16(2):e0243183. PubMed ID: 33621263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.